News

Leading insurance provider Progressive PGR is set to report Q1 results on Wednesday before the opening bell. A Zacks Rank #3 (Hold), Progressive missed the earnings mark in two of the past four

The Travelers Companies, Inc. TRV has delivered solid financial performance over the past year, supported by consistent revenue growth. In 2025, the company generated approximately $48.8 billion in

Hertz Global Holdings HTZ is seeing travel behavior shift in ways that can support a steadier recovery path into 2026. Pricing is stabilizing, depreciation is improving as used car values normalize

Volkswagen VWAGY reported global deliveries of 2,048,900 vehicles in the first quarter of 2026, reflecting a 4% year-over-year decline, as weak demand in key markets weighed on performance. The

IDEXX Laboratories, Inc. IDXX is expanding its global commercial capabilities to support continued growth in its CAG Diagnostics recurring revenue stream. The company’s software ecosystem remains a

IonQ IONQ continues to advance quantum networking and real-world applications through strategic collaborations with leading academic partners. In line with this, IonQ and the University of Maryland

Northrop Grumman Corporation NOC is scheduled to release first-quarter 2026 results on April 21, before market open. The company delivered an earnings surprise of 3.3% in the last reported quarter

Regeneron Pharmaceuticals REGN announced that it has entered into a strategic collaboration with Telix Pharmaceuticals Limited TLX to co-develop and co-commercialize next-generation

Visa Inc. V recently announced a new partnership with Neat to enhance the insurance and medical assistance services embedded within its cards. The collaboration underscores a broader move toward

Medline Inc. (MDLN recently received a warning letter from the FDA, citing multiple violations related to manufacturing and quality system processes at its New York facility. The regulatory action

Artificial Intelligence (AI) is reshaping the software landscape, redefining categories and competitive dynamics. Per The Business Research Company, the AI software market is projected to grow to

Hertz Global Holdings HTZ is trying to turn improving fundamentals into a more durable earnings and cash flow profile. Pricing is stabilizing, fleet economics are getting a lift from lower

Growth investors focus on stocks that are seeing above-average financial growth, as this feature helps these securities garner the market's attention and deliver solid returns. But finding a great

Investors seek growth stocks to capitalize on above-average growth in financials that help these securities grab the market's attention and produce exceptional returns. However, it isn't easy to

Growth stocks are attractive to many investors, as above-average financial growth helps these stocks easily grab the market's attention and produce exceptional returns. But finding a growth stock

Investors seek growth stocks to capitalize on above-average growth in financials that help these securities grab the market's attention and produce exceptional returns. But finding a great growth

Growth investors focus on stocks that are seeing above-average financial growth, as this feature helps these securities garner the market's attention and deliver solid returns. However, it isn't

Shares of Uber Technologies UBER) have declined 23.4% over the past six months against the Zacks  Internet-Services industry’s growth of 20.7%. However, it outperformed fellow industry players, Lyft

GigaCloud Technology GCT and Red Cat Holdings RCAT are key participants in the Zacks Technology Services industry. Based in California, GigaCloud Technology is a prominent provider of end-to-end

Kymera Therapeutics KYMR announced that the FDA has granted a Fast Track designation to its lead candidate, KT-621, for the treatment of moderate-to-severe eosinophilic asthma. KYMR shares rose 4%

Nu Holdings Ltd. NU is currently trading at a 16.1X forward 12-month price-to-earnings, substantially higher than the industry’s 10.91X. While the stock appears expensive, the forward-looking

Shares of Revolution Medicines RVMD surged 41% after the company announced that its pivotal phase III RASolute 302 study evaluating daraxonrasib, its lead pipeline candidate in previously treated

Optimism around a potential long-term truce in the Middle East lifted U.S. markets, with the S&P 500 Index rising about 0.93% over the past five days. The increase reflects growing investor

Invesco S&P 500 Momentum ETF SPMO is probably on the radar for investors seeking momentum. The fund just hit a 52-week high and has moved up 46.84% from its 52-week low price of $84.86 per share.

Johnson & Johnson’s JNJ first-quarter 2026 earnings came in at $2.70 per share, which beat the Zacks Consensus Estimate of $2.67. Earnings declined 2.5% from the year-ago period.

Adjusted earnings